Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions

Monique Roobol - Bouts, S Carlsson, J Hugosson

Research output: Contribution to journalArticleAcademic

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)20-21
Number of pages2
JournalEvidence-Based Medicine
Issue number1
Publication statusPublished - 2011

Research programs

  • EMC MM-03-49-01

Cite this